Lachlan McDowell

Peter MacCallum Cancer Centre

Papers

1

Total Citations

2

H-Index

1

About

Dr. Lachlan McDowell is a leading clinician-researcher in head and neck surgical oncology, with a primary focus on transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma. His work centers on optimizing functional outcomes and quality of life after treatment, particularly regarding patients’ ability to return to work. In his highly cited 2024 study, Dr. McDowell demonstrated that early return to work is achievable in carefully selected patients undergoing TORS, with the greatest benefit seen in those who avoid adjuvant therapy. He identified key barriers—such as the physical impacts of treatment—and facilitators, including flexible working arrangements and supportive employers. This research has significant implications for patient counseling and rehabilitation protocols, helping to shift the paradigm from mere survival to meaningful recovery. With 2 citations already, his work is gaining traction among surgeons and rehabilitation specialists. Dr. McDowell’s contributions are notable for bridging surgical innovation with practical, patient-centered outcomes, making him a valuable voice in the evolving field of minimally invasive head and neck cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Early return to work is possible after transoral robotic surgery (TORS) in carefully selected patients with oropharyngeal squamous cell carcinoma
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Peter MacCallum Cancer Centre

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago